We have frequently written on AGs interest in AI. In what Texas calls the “first-of-its-kind healthcare generative AI” settlement, the state resolved its investigation into Pieces Technologies’ alleged misleading statements about accuracy of products deployed in major hospitals. Pieces claimed the product “summarizes, charts, and drafts clinical notes for your doctors and nurses…so they don’t have to.” The company further claimed accuracy of a <1 per 100,000 “severe hallucination rate,” a “phenomena of generative AI products creating an output that is incorrect or misleading.” Texas found this to be “likely inaccurate” and alleged these representations “may have violated the DTPA.”
https://www.kelleydrye.com/viewpoints/blogs/ad-law-access/the-eyes-of-texas-are-on-ai-generative-ai-settlement-reached
Paul Singer
[email protected]
(202) 342-8672
www.kelleydrye.com/Our-People/Paul-L-Singer
Alysa Hutnik
[email protected]
(202) 342-8603
www.kelleydrye.com/people/alysa-z-hutnik
Abigail Stempson
[email protected]
(202) 342-8678
www.kelleydrye.com/Our-People/Abigail-Stempson
Beth Chun
[email protected]
(202) 342-8671
www.kelleydrye.com/Our-People/Beth-Bolen-Chun
Subscribe to the Ad Law Access blog - www.kelleydrye.com/subscribe
Subscribe to the Ad Law News Newsletter - www.kelleydrye.com/subscribe
View the Advertising and Privacy Law Resource Center - www.kelleydrye.com/advertising-and-privacy-law
Find all of our links here linktr.ee/KelleyDryeAdLaw
Hosted by Simone Roach